Search CDMOs

• ADC Payload & Linker Synthesis
• CMC Analytical Development
• Controlled Substance Manufacturing

Contract process R&D and cGMP manufacturing for small molecule pharmaceuticals, specializing in high-potent compounds, controlled substances, crystallization development, and analytical services across Phase 1–3 clinical programs.

• Allogeneic Cell Therapy Manufacturing
• CMC Analytical Development
• Autologous Cell Therapy Manufacturing

Bramble Bio specializes in cGMP manufacturing and process development for cell therapy ATIMPs, including autologous and allogeneic therapies, with 20+ years of expertise, 16 Grade B cleanrooms, and support for over 8,000 dosed patients across 46 countries.

• AAV Manufacturing
• CMC Analytical Development
• Biologics Development & Manufacturing

Asimov provides cell line development, upstream process development, and viral vector manufacturing services powered by proprietary synthetic biology platforms (CHO Edge, LV Edge, AAV Edge, RNA Edge) that deliver high-titer, stable cell lines and production systems for biologics, cell therapies, and gene therapies.

• ADC Payload & Linker Synthesis
• CMC Analytical Development
• API Synthesis & Manufacturing

Tenova Pharma supplies chemical probes, advanced linkers, and ADC payloads alongside custom synthesis and medicinal chemistry services for drug discovery and life science research.

• AAV Manufacturing
• Allogeneic Cell Therapy Manufacturing
• CMC Analytical Development

UK-based innovation and manufacturing support organization for cell and gene therapies, offering infrastructure, expertise, and collaboration across the ATMP lifecycle.

• ADC (Antibody-Drug Conjugate) Manufacturing
• ADC Payload & Linker Synthesis
• CMC Analytical Development

Integrated CRDMO offering discovery, development, and manufacturing services for small molecule NCE programs across 280+ global pharma and biotech clients.

• AAV Manufacturing
• ADC (Antibody-Drug Conjugate) Manufacturing
• ADC Payload & Linker Synthesis

Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.

• ADC (Antibody-Drug Conjugate) Manufacturing
• ADC Payload & Linker Synthesis
• CMC Analytical Development

WuXi XDC is a leading CRDMO offering integrated discovery, development, and cGMP manufacturing services for antibody drug conjugates (ADCs) and bioconjugates, with proximately located facilities that reduce development timelines and costs.

• ADC (Antibody-Drug Conjugate) Manufacturing
• ADC Payload & Linker Synthesis
• CMC Analytical Development

Global CMO offering small and large molecule drug substance to drug product manufacturing, with specialized capabilities in antibody drug conjugates, aseptic fill-finish, biologics (mAbs), HPAPI, and eye care across 12 facilities in the US and Europe.